New Zealand markets open in 4 hours 47 minutes

Hansoh Pharmaceutical Group Company Limited (3692.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
16.320-0.160 (-0.97%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 96.78B
Enterprise value 74.69B
Trailing P/E 29.20
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.05
Price/book (mrq)3.49
Enterprise value/revenue 6.88
Enterprise value/EBITDA 16.55

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 325.93%
S&P500 52-week change 322.55%
52-week high 318.760
52-week low 39.410
50-day moving average 317.147
200-day moving average 314.423

Share statistics

Avg vol (3-month) 34.72M
Avg vol (10-day) 33.07M
Shares outstanding 55.93B
Implied shares outstanding 65.99B
Float 81.07B
% held by insiders 181.75%
% held by institutions 110.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.21
Forward annual dividend yield 41.30%
Trailing annual dividend rate 30.19
Trailing annual dividend yield 31.17%
5-year average dividend yield 4N/A
Payout ratio 421.36%
Dividend date 3N/A
Ex-dividend date 419 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 32.44%
Operating margin (ttm)29.24%

Management effectiveness

Return on assets (ttm)5.31%
Return on equity (ttm)13.53%

Income statement

Revenue (ttm)10.1B
Revenue per share (ttm)1.71
Quarterly revenue growth (yoy)13.00%
Gross profit (ttm)N/A
EBITDA 3.02B
Net income avi to common (ttm)3.28B
Diluted EPS (ttm)0.560
Quarterly earnings growth (yoy)54.70%

Balance sheet

Total cash (mrq)24.88B
Total cash per share (mrq)4.2
Total debt (mrq)4.3B
Total debt/equity (mrq)16.69%
Current ratio (mrq)4.21
Book value per share (mrq)4.35

Cash flow statement

Operating cash flow (ttm)3.12B
Levered free cash flow (ttm)2.07B